Bank of Montreal Can bought a new position in shares of Safeguard Scientifics Inc. (NYSE:SFE) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm bought 453,481 shares of the company’s stock, valued at approximately $5,664,000.
Other hedge funds and other institutional investors have also recently modified their holdings of the company. Keane Capital Partners LLC bought a new position in Safeguard Scientifics during the first quarter valued at approximately $1,132,000. BlackRock Group LTD raised its position in Safeguard Scientifics by 38.2% in the first quarter. BlackRock Group LTD now owns 113,075 shares of the company’s stock valued at $1,498,000 after buying an additional 31,256 shares during the period. Geode Capital Management LLC raised its position in Safeguard Scientifics by 5.8% in the first quarter. Geode Capital Management LLC now owns 133,856 shares of the company’s stock valued at $1,773,000 after buying an additional 7,330 shares during the period. Renaissance Technologies LLC raised its position in Safeguard Scientifics by 216.0% in the first quarter. Renaissance Technologies LLC now owns 94,800 shares of the company’s stock valued at $1,256,000 after buying an additional 64,800 shares during the period. Finally, Yakira Capital Management Inc. raised its position in Safeguard Scientifics by 14.3% in the first quarter. Yakira Capital Management Inc. now owns 487,645 shares of the company’s stock valued at $6,461,000 after buying an additional 60,823 shares during the period. Hedge funds and other institutional investors own 78.62% of the company’s stock.
Safeguard Scientifics Inc. (NYSE:SFE) traded down 2.46% on Tuesday, reaching $13.09. The company’s stock had a trading volume of 36,065 shares. The stock has a 50 day moving average price of $13.46 and a 200-day moving average price of $13.32. The company’s market capitalization is $264.73 million. Safeguard Scientifics Inc. has a 1-year low of $11.40 and a 1-year high of $18.07.
Safeguard Scientifics (NYSE:SFE) last announced its earnings results on Thursday, July 28th. The company reported $1.92 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.47 by $0.45. During the same quarter last year, the company earned ($0.91) EPS. Equities analysts predict that Safeguard Scientifics Inc. will post $0.24 earnings per share for the current fiscal year.
Separately, Zacks Investment Research lowered Safeguard Scientifics from a “buy” rating to a “hold” rating in a research report on Thursday, June 30th.
In other news, CEO Stephen T. Zarrilli bought 3,900 shares of the business’s stock in a transaction on Wednesday, September 14th. The shares were bought at an average cost of $12.75 per share, with a total value of $49,725.00. Following the purchase, the chief executive officer now directly owns 103,606 shares in the company, valued at $1,320,976.50. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. Company insiders own 2.67% of the company’s stock.
Safeguard Scientifics Company Profile
Safeguard Scientifics, Inc provides capital, as well as strategic, operational and management resources to growth-stage businesses. The Company participates in early- and growth-stage financings. The Company operates through two segments: Healthcare and Technology. The Healthcare segment’s companies focuses principally on medical technology (MedTech), including diagnostics and devices, and healthcare technology (HealthTech).
Want to see what other hedge funds are holding SFE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Safeguard Scientifics Inc. (NYSE:SFE).
Receive News & Ratings for Safeguard Scientifics Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Safeguard Scientifics Inc. and related companies with MarketBeat.com's FREE daily email newsletter.